Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) EBT (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported EBT of -$51.6 million for Q2 2026, compared with -$4.87 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) EBT (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lb Pharmaceuticals' EBT came in at -$85.68 million; for FY2025, it was -$25.2 million.

  • By year, EBT came in at -$63.1 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly EBT in data going back to Q3 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$19.05 million (Q1 2026), -$11.47 million (Q4 2025) and -$3.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 34.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.83 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.96 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.69 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.06 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.39 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - -59.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -59.07 Mn
Jun 30, 2026 -51.60 Mn
Mar 31, 2026 -19.05 Mn
Dec 31, 2025 -11.47 Mn
Sep 30, 2025 -3.56 Mn
Jun 30, 2025 -4.87 Mn
Mar 31, 2025 -5.31 Mn
Dec 31, 2024 -5.07 Mn
Sep 30, 2024 -14.18 Mn
API Access

Lb Pharmaceuticals EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=LBRX&period=max&api_key=YOUR_API_KEY